Oncolytics Biotech Dirección
Dirección controles de criterios 2/4
El CEO de Oncolytics Biotech's es Matt Coffey , nombrado en Jan 2016, tiene una permanencia de 8.25 años. compensación anual total es CA$2.25M, compuesta por 32.7% salario y 67.3% primas, incluidas acciones y opciones de la empresa. posee directamente un 1.97% de las acciones de la empresa, por valor de CA$2.21M. La antigüedad media del equipo directivo y de la junta directiva es de 5.2 años y 6.4 años, respectivamente.
Información clave
Matt Coffey
Chief Executive Officer (CEO)
CA$2.2m
Compensación total
| Porcentaje del salario del CEO | 32.7% |
| Permanencia del CEO | 8.3yrs |
| Participación del CEO | 0.1% |
| Permanencia media de la dirección | 5.3yrs |
| Promedio de permanencia en la Junta Directiva | 6.5yrs |
Actualizaciones recientes de la dirección
Recent updates
We Think Oncolytics Biotech (TSE:ONC) Needs To Drive Business Growth Carefully
Feb 23
Is Oncolytics Biotech (TSE:ONC) In A Good Position To Deliver On Growth Plans?
Nov 10We Think Oncolytics Biotech (TSE:ONC) Needs To Drive Business Growth Carefully
Jul 07Is Oncolytics Biotech (TSE:ONC) In A Good Position To Deliver On Growth Plans?
Mar 24Is Oncolytics Biotech (TSE:ONC) In A Good Position To Invest In Growth?
Dec 09We're Keeping An Eye On Oncolytics Biotech's (TSE:ONC) Cash Burn Rate
Aug 25Here's Why We're Watching Oncolytics Biotech's (TSE:ONC) Cash Burn Situation
May 12We Think Oncolytics Biotech (TSE:ONC) Can Afford To Drive Business Growth
Dec 02We Think Oncolytics Biotech (TSE:ONC) Can Afford To Drive Business Growth
Aug 05Companies Like Oncolytics Biotech (TSE:ONC) Are In A Position To Invest In Growth
Apr 15We Think Oncolytics Biotech (TSE:ONC) Needs To Drive Business Growth Carefully
Dec 31Análisis de compensación del CEO
| Fecha | Compensación total | Salario | Ingresos de la empresa |
|---|---|---|---|
| Dec 31 2023 | CA$2m | CA$735k | -CA$28m |
| Sep 30 2023 | n/a | n/a | -CA$32m |
| Jun 30 2023 | n/a | n/a | -CA$27m |
| Mar 31 2023 | n/a | n/a | -CA$24m |
| Dec 31 2022 | CA$1m | CA$654k | -CA$25m |
| Sep 30 2022 | n/a | n/a | -CA$24m |
| Jun 30 2022 | n/a | n/a | -CA$24m |
| Mar 31 2022 | n/a | n/a | -CA$27m |
| Dec 31 2021 | CA$2m | CA$637k | -CA$26m |
| Sep 30 2021 | n/a | n/a | -CA$28m |
| Jun 30 2021 | n/a | n/a | -CA$30m |
| Mar 31 2021 | n/a | n/a | -CA$29m |
| Dec 31 2020 | CA$1m | CA$541k | -CA$23m |
| Sep 30 2020 | n/a | n/a | -CA$33m |
| Jun 30 2020 | n/a | n/a | -CA$29m |
| Mar 31 2020 | n/a | n/a | -CA$28m |
| Dec 31 2019 | CA$965k | CA$525k | -CA$33m |
| Sep 30 2019 | n/a | n/a | -CA$19m |
| Jun 30 2019 | n/a | n/a | -CA$18m |
| Mar 31 2019 | n/a | n/a | -CA$17m |
| Dec 31 2018 | CA$2m | CA$475k | -CA$17m |
| Sep 30 2018 | n/a | n/a | -CA$17m |
| Jun 30 2018 | n/a | n/a | -CA$17m |
| Mar 31 2018 | n/a | n/a | -CA$17m |
| Dec 31 2017 | CA$726k | CA$430k | -CA$16m |
Compensación vs. Mercado: La compensación total de Matt($USD1.64M) está por encima de la media de empresas de tamaño similar en el mercado Canadian ($USD174.90K).
Compensación vs. Ingresos: La compensación de Matt ha aumentado mientras la empresa no es rentable.
CEO
Matt Coffey
8.3yrs
Permanencia
CA$2,246,023
Compensación
Dr. Matthew C. Coffey, also known as Matt, Ph D., M.B.A., Co-founded Oncolytics Biotech Inc., and has been its Chief Executive Officer since 2016 and President since January 19, 2017. He has been a Directo...
Equipo directivo
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 8.3yrs | CA$2.25m | 0.13% CA$ 154.1k | |
| Chief Financial Officer | 11.5yrs | CA$1.32m | 1.18% CA$ 1.4m | |
| Chief Medical Officer | 2.4yrs | CA$1.36m | 0.68% CA$ 825.9k | |
| Vice President of Product Development | 5.6yrs | CA$727.64k | 0.69% CA$ 826.7k | |
| Vice President of Clinical Operations | 1.3yrs | CA$683.55k | sin datos | |
| Director of Investor Relations & Communication | no data | sin datos | sin datos | |
| Consultant | 5yrs | CA$25.98k | sin datos |
5.3yrs
Permanencia media
Equipo directivo experimentado: El equipo directivo de ONC es experimentado (5.2 años antigüedad media).
Miembros de la Junta
| Nombre | Posición | Permanencia | Compensación | Propiedad |
|---|---|---|---|---|
| President | 13yrs | CA$2.25m | 0.13% CA$ 154.1k | |
| Independent Director | 8.9yrs | CA$123.96k | 0.50% CA$ 608.2k | |
| Independent Director | 1.9yrs | CA$116.36k | sin datos | |
| Independent Director | 1.8yrs | CA$107.40k | 0.42% CA$ 503.8k | |
| Independent Chairman of the Board | 11yrs | CA$165.01k | 0.25% CA$ 303.9k | |
| Independent Director | 9.9yrs | CA$130.58k | 0.17% CA$ 203.6k | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Independent Director | 6.5yrs | CA$124.95k | 0.065% CA$ 78.3k | |
| Member of Scientific Advisory Board | 6.5yrs | sin datos | sin datos | |
| Member of Scientific Advisory Board | no data | sin datos | sin datos | |
| Member of Scientific Advisory Board | 3.6yrs | sin datos | sin datos |
6.5yrs
Permanencia media
67.5yo
Promedio de edad
Junta con experiencia: La junta directiva de ONC se considera experimentada (6.4 años de antigüedad promedio).